OPK
Opko Health Inc
NASDAQ: OPK · HEALTHCARE · DIAGNOSTICS & RESEARCH
$1.12
-1.37% today
Updated 2026-06-05
Market cap
$1.06B
P/E ratio
—
P/S ratio
1.82x
EPS (TTM)
$-0.27
Dividend yield
—
52W range
$1 – $2
Volume
2.5M
Opko Health Inc (OPK) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$1.12
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.8B | $1.0B | $0.9B | $0.7B | $0.6B | $0.5B | $0.4B | $0.4B | $0.3B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: -15.82% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -36.60%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.